* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
None
What’s baking in the oven?
Reverse Transactions:***
18 February: AIM quoted Beacon Energy (BCE.L) suspended on 27 June 2025, has today published an Admission Document in relation to the Proposed Transaction announced on 7 October 2025 to make a significant strategic investment in LNEnergy Limited which constitutes a reverse takeover and raise gross proceeds of approximately £3.75m. The AGM is set for 5 March with restoration of trading of the enlarged shared capital expected on 6 March.
Market Movers:***
14 January: GlobalData (DATA.L), the data, insight, and technology Company expects to submit its application to move to the Main Market from AIM and to take place on 5 March.
Banquet Buffet****
80 Mile 0.98p £48.56m (80M.L)
The AIM, FSE, and OTC listed exploration and development Company with projects in Greenland, Finland and Italy confirms that the SEC has approved the proposed acquisition by Pelican Acquisition Corporation (PELI), the NASDAQ-listed special purpose acquisition company, of Greenland Exploration Limited, and March GL, and, subject only to shareholder approval, is now set to start trading on NASDAQ as Greenland Energy Company. Under the terms of 80 Mile's definitive joint venture agreement, PELI is entitled to earn up to a 70% working interest in Jameson by funding 100% of the costs associated with up to two exploration wells, each to a minimum depth of approximately 3,500 metres. 80 Mile will retain a 30% interest in Jameson through its wholly owned subsidiary White Flame Energy A/S.
Catenai 0.24p £3.30m (CTAI.L)
The provider of technology and digital solutions notes that Alludium, its investee company and developer of a no-code AI Agent Operating System, has been recognised as a Select tier partner within the Google Cloud Partner Network. Select tier status is an earned designation within Google Cloud's updated partner model, recognising demonstrated proficiency and customer impact across Google Cloud and Google Workspace. The recognition reflects Alludium's technical alignment and integration capabilities across key Google Workspace tools, including Gmail, Google Calendar and Google Drive.
Checkit 19.00p £18.63m (CKT.L)
The automated monitoring and operational intelligence platform for frontline-led organisations updates on trading FY January 2026. The adjusted EBITDA is at break-even which is ahead of market expectations, following delivery of £4.0m of annualised cost savings marking a significant inflexion point. The YE net cash improved to £3.0m from £2.7m at 31 July 2025, reflecting a cash-generative H2. The recurring revenue increased to 96% of total revenue of £13.7m. The Company enters FY27 with a materially lower cost base, improved operational discipline and a high-quality pipeline. In the year ahead, the Group will continue to refine its resource allocation, with increased emphasis on its core platform, which the Company believes offers the strongest long-term value opportunity.
Genedrive 1.10p £11.99m (GDR.L)
The point of care pharmacogenetic testing Company confirms the completion of a placing, and announced an open offer to qualifying shareholders. This is additional to the £3.5m raised at 1p in a direct subscription that was announced 13 February. The proceeds are to continue near-term commercialisation and market expansion activities in the UK, Europe and the Middle East. The FDA 510 submission for the lead drug CYP2C19 is anticipated around June 2026, with an expected 3-4 month review period post submission. Funds will also be used to scale up the manufacturing to increase efficiencies. Dr. Gino Miele and Russ Shaw, the Company's CEO and CFO, respectively, each intend to subscribe for £50k worth of Shares under the terms of the Open Offer.
Jubilee Metals Group 4.00p £127.42m (JLP.L)
The Zambia copper focused producer today published its unaudited operational and projects update for the half year ended 31 December 2025. Lost Time Frequency Injury Rate was 1.20, up from 0.61 the previous year, however Total saleable copper units rose 8.7% to 1,543 tonnes, underpinned by a 172.8% production increase at the Roan Operations and steady output at the Molefe Mine, even as heavy rains damaged local infrastructure. The copper unit production guidance for FY2026 remains within the range of 4,500t to 5,100t depending on the extent of the impact on production during the rainy season (FY2025 production: 2,211t).
Mindflair 0.58p £3.03m (MFAI.L)
The AIM-quoted Company focused on investing in Artificial Intelligence and related technology notes that Mirror Security Limited, a Dublin-based Cybersecurity Company specialising in data protection across the generative AI ecosystem, has announced full production availability of its Encrypted AI Inference platform utilising NVIDIA Accelerated Computing, solving a problem that has blocked AI adoption in healthcare, finance, government and defence. Mirror is a portfolio company held within Sure Valley Ventures' third fund, in which Mindflair holds an interest.
Panther Metals 85.00p £6.95m (PALM.L)*
The mineral Company focused on projects in Canada announced that it has signed a letter of interest with Traxys Europe SA, a division of Traxys Group, a global commodity trading and marketing market leader. The non-binding LOI concerns Panther's Winston Tailings Project and is a formal recognition of an ongoing engagement between both parties as Panther progresses work to declare a Mineral Resource estimate, as part of a series of ongoing workstreams to quantify, evaluate and permit the contained high-grade gold, gallium, silver, zinc, copper, indium and cobalt and other recoverable minerals located within the historic Winston Lake Mine tailings storage facility near Schrieber, Ontario, Canada.
Quantum Data Energy 2.20p £4.24m (MAST.L)
The reserve power Company announced further to its RNS announcements dated 3 and 9 February, that the Company is continuing to make progress to get its third flexible generation power project to financial close and into construction and commercial operations. The Company (QDE) is in advanced discussions with Power Balancing Services (PBS) regarding QDE's 100% owned Bordersley 5 MW flexible generation project, as previously announced. QDE has agreed in principle with PBS to co-fund the capex of its Bordesley 5MW flexgen project, and the capex funding will be structured at project SPV level. QDE and PBS are busy finalising the investment agreement which is in near final agreed form, and expected to be executed and completed shortly at which time the key terms of the transaction will be announced.
Rome Resources 0.29p £20.40m (RMR.L)
The DRC-focused tin and copper explorer, announced the results of recent geological interpretation work conducted at its Mont Agoma prospect within the Bisie North project in the Democratic Republic of Congo, with the Company identifying new, high-priority exploration zones for tin and copper. The work confirmed that the tin and copper mineralisation at the site by Chemostrat confirms mineralisation is ‘geologically predictable’.
Thruvision Group 0.93p £3.92m (THRU.L)
The developer, manufacturer and supplier of walk-through security screening technology announces that it has secured multiple new contracts to deploy its 8108 SpotCHECK advanced people-screening technology across UK custodial facilities, with deliveries scheduled by 31 March. Each installation secured includes a five-year contracted support and maintenance agreement, strengthening long-term customer relationships and enhancing recurring revenue visibility.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
